| histone modification | GO:0016570 | 159 | 0.992 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.991 | |
| chromatin organization | GO:0006325 | 206 | 0.986 | |
| chromatin modification | GO:0016568 | 187 | 0.978 | |
| histone methylation | GO:0016571 | 71 | 0.889 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.857 | |
| histone h2a ubiquitination | GO:0033522 | 3 | 0.845 | |
| protein dealkylation | GO:0008214 | 13 | 0.845 | |
| dna metabolic process | GO:0006259 | 303 | 0.726 | |
| histone lysine demethylation | GO:0070076 | 13 | 0.715 | |
| histone demethylation | GO:0016577 | 13 | 0.707 | |
| cell fate commitment | GO:0045165 | 210 | 0.688 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.684 | |
| macromolecule methylation | GO:0043414 | 120 | 0.681 | |
| protein demethylation | GO:0006482 | 13 | 0.673 | |
| oocyte axis specification | GO:0007309 | 2 | 0.645 | |
| protein methylation | GO:0006479 | 81 | 0.636 | |
| methylation | GO:0032259 | 134 | 0.582 | |
| histone h3 k36 demethylation | GO:0070544 | 2 | 0.576 | |
| histone h2a monoubiquitination | GO:0035518 | 1 | 0.568 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.541 | |
| demethylation | GO:0070988 | 23 | 0.507 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.476 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.453 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.423 | |
| pole plasm assembly | GO:0007315 | 2 | 0.400 | |
| cell maturation | GO:0048469 | 127 | 0.387 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.384 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.373 | |
| oocyte construction | GO:0007308 | 2 | 0.369 | |
| positive regulation of immature t cell proliferation | GO:0033091 | 4 | 0.313 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.304 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.285 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.276 | |
| protein alkylation | GO:0008213 | 81 | 0.275 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.264 | |
| regionalization | GO:0003002 | 337 | 0.262 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.240 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.235 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.223 | |
| mrna processing | GO:0006397 | 63 | 0.220 | |
| tube formation | GO:0035148 | 140 | 0.220 | |
| spermatogenesis | GO:0007283 | 284 | 0.220 | |
| axonogenesis | GO:0007409 | 274 | 0.213 | |
| cellular response to lipid | GO:0071396 | 145 | 0.211 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.207 | |
| histone monoubiquitination | GO:0010390 | 3 | 0.199 | |
| dna methylation | GO:0006306 | 43 | 0.199 | |
| organelle fission | GO:0048285 | 170 | 0.194 | |
| nuclear division | GO:0000280 | 158 | 0.188 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.184 | |
| protein acylation | GO:0043543 | 64 | 0.182 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.179 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.178 | |
| neural tube formation | GO:0001841 | 108 | 0.175 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.172 | |
| histone lysine methylation | GO:0034968 | 50 | 0.166 | |
| stem cell development | GO:0048864 | 219 | 0.165 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.165 | |
| germ cell development | GO:0007281 | 185 | 0.161 | |
| neural tube development | GO:0021915 | 160 | 0.157 | |
| dna modification | GO:0006304 | 50 | 0.154 | |
| midbrain hindbrain boundary morphogenesis | GO:0021555 | 4 | 0.152 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.151 | |
| dna alkylation | GO:0006305 | 43 | 0.146 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.145 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.143 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.139 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.136 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.135 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.133 | |
| epithelial tube formation | GO:0072175 | 130 | 0.132 | |
| developmental maturation | GO:0021700 | 193 | 0.130 | |
| histone acetylation | GO:0016573 | 41 | 0.130 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.128 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.128 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.127 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.125 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.124 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.123 | |
| regulation of histone modification | GO:0031056 | 56 | 0.122 | |
| gene silencing by rna | GO:0031047 | 19 | 0.120 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.118 | |
| neural tube closure | GO:0001843 | 90 | 0.116 | |
| negative regulation of histone modification | GO:0031057 | 18 | 0.115 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.115 | |
| mrna metabolic process | GO:0016071 | 84 | 0.115 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.110 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.110 | |
| negative regulation of histone methylation | GO:0031061 | 10 | 0.109 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.108 | |
| regulation of protein stability | GO:0031647 | 52 | 0.108 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.107 | |
| camera type eye development | GO:0043010 | 266 | 0.106 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.105 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.103 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.102 | |
| protein catabolic process | GO:0030163 | 221 | 0.102 | |
| organelle assembly | GO:0070925 | 177 | 0.100 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.095 | Human |
| histone h3 k9 dimethylation | GO:0036123 | 4 | 0.095 | |
| dna repair | GO:0006281 | 107 | 0.095 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.093 | |
| fourth ventricle development | GO:0021592 | 2 | 0.092 | |
| tube closure | GO:0060606 | 91 | 0.091 | |
| transcription from rna polymerase i promoter | GO:0006360 | 13 | 0.090 | |
| protein ubiquitination | GO:0016567 | 171 | 0.090 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.089 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.086 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.086 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.086 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.085 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.083 | |
| axon guidance | GO:0007411 | 141 | 0.078 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.078 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.076 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.075 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.075 | |
| rna processing | GO:0006396 | 105 | 0.075 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.073 | |
| gene silencing | GO:0016458 | 38 | 0.072 | |
| histone deacetylation | GO:0016575 | 26 | 0.071 | |
| histone ubiquitination | GO:0016574 | 10 | 0.071 | |
| oogenesis | GO:0048477 | 56 | 0.071 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.071 | |
| cell division | GO:0051301 | 120 | 0.070 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.070 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.070 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.069 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.069 | |
| rna interference | GO:0016246 | 2 | 0.068 | |
| regulation of histone h3 k36 methylation | GO:0000414 | 1 | 0.067 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.067 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.066 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.065 | Human |
| gonad development | GO:0008406 | 141 | 0.064 | |
| histone h3 k27 demethylation | GO:0071557 | 4 | 0.064 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.062 | Human |
| circadian rhythm | GO:0007623 | 114 | 0.062 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.061 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.060 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.060 | |
| protein deacetylation | GO:0006476 | 32 | 0.058 | |
| histone h3 k36 methylation | GO:0010452 | 6 | 0.057 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.057 | Human |
| b cell activation | GO:0042113 | 161 | 0.057 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.057 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.056 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.056 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.056 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.056 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.055 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.054 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.054 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.054 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.053 | |
| segmentation | GO:0035282 | 93 | 0.053 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.052 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.052 | |
| skeletal system development | GO:0001501 | 356 | 0.052 | |
| cell adhesion | GO:0007155 | 329 | 0.052 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.051 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.051 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.051 | |
| regulation of neuron death | GO:1901214 | 134 | 0.051 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.051 | |
| blastocyst development | GO:0001824 | 80 | 0.050 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.050 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.049 | |
| placenta development | GO:0001890 | 140 | 0.049 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.048 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.048 | |
| neuron death | GO:0070997 | 154 | 0.048 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.047 | |
| rhythmic process | GO:0048511 | 174 | 0.046 | |
| b cell proliferation | GO:0042100 | 53 | 0.045 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.045 | |
| double strand break repair | GO:0006302 | 48 | 0.045 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.045 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.045 | Human |
| protein autophosphorylation | GO:0046777 | 61 | 0.045 | |
| snrna metabolic process | GO:0016073 | 1 | 0.044 | |
| rna splicing | GO:0008380 | 54 | 0.043 | |
| t cell activation | GO:0042110 | 289 | 0.043 | |
| neural tube patterning | GO:0021532 | 43 | 0.042 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.042 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.042 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.042 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.041 | |
| neuron projection guidance | GO:0097485 | 141 | 0.041 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.040 | |
| regulation of cell division | GO:0051302 | 76 | 0.040 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.040 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.039 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.038 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.037 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.037 | |
| positive regulation of hh target transcription factor activity | GO:0007228 | 3 | 0.036 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.036 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.036 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.036 | |
| regulation of cell activation | GO:0050865 | 289 | 0.036 | |
| hindbrain development | GO:0030902 | 128 | 0.036 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.035 | |
| locomotory behavior | GO:0007626 | 195 | 0.035 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.035 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.035 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.034 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.034 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.034 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.034 | |
| negative regulation of transcription from rna polymerase i promoter | GO:0016479 | 2 | 0.034 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.034 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.033 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.033 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.033 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.033 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.033 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.033 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.033 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.032 | |
| rna localization | GO:0006403 | 23 | 0.032 | |
| muscle tissue development | GO:0060537 | 308 | 0.032 | |
| oocyte development | GO:0048599 | 33 | 0.032 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.032 | |
| positive regulation of b cell activation | GO:0050871 | 49 | 0.031 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.031 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.031 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.031 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.030 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.030 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.030 | |
| positive regulation of growth | GO:0045927 | 104 | 0.030 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.030 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.030 | |
| response to nutrient levels | GO:0031667 | 109 | 0.029 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.029 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.029 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.029 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.029 | |
| cell growth | GO:0016049 | 130 | 0.029 | |
| male gamete generation | GO:0048232 | 285 | 0.029 | |
| female gamete generation | GO:0007292 | 74 | 0.029 | |
| regulation of cell growth | GO:0001558 | 91 | 0.028 | |
| atp catabolic process | GO:0006200 | 55 | 0.028 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.028 | |
| oocyte differentiation | GO:0009994 | 35 | 0.028 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.028 | |
| chronological cell aging | GO:0001300 | 1 | 0.028 | |
| histone h3 k9 demethylation | GO:0033169 | 5 | 0.028 | |
| protein deacylation | GO:0035601 | 36 | 0.028 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.028 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.028 | |
| response to radiation | GO:0009314 | 165 | 0.027 | |
| regulation of binding | GO:0051098 | 111 | 0.027 | Human |
| chemotaxis | GO:0006935 | 247 | 0.027 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.027 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.027 | |
| sensory perception of sound | GO:0007605 | 97 | 0.027 | |
| lateral inhibition | GO:0046331 | 1 | 0.027 | |
| cell aging | GO:0007569 | 35 | 0.027 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.027 | Human |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.026 | |
| rostrocaudal neural tube patterning | GO:0021903 | 12 | 0.026 | |
| response to drug | GO:0042493 | 75 | 0.026 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.026 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.026 | |
| heterochromatin organization | GO:0070828 | 4 | 0.026 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.026 | |
| cellular response to sterol | GO:0036315 | 2 | 0.026 | |
| telencephalon development | GO:0021537 | 186 | 0.025 | |
| stem cell division | GO:0017145 | 30 | 0.025 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.025 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.025 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.025 | |
| odontogenesis | GO:0042476 | 78 | 0.025 | |
| connective tissue development | GO:0061448 | 179 | 0.025 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.025 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.024 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.024 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.024 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.024 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.024 | |
| stem cell differentiation | GO:0048863 | 268 | 0.024 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.024 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.024 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.024 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.024 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.024 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.024 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.024 | Human |
| response to inorganic substance | GO:0010035 | 96 | 0.024 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.024 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.023 | |
| positive regulation of t cell differentiation in thymus | GO:0033089 | 13 | 0.023 | |
| protein targeting | GO:0006605 | 143 | 0.023 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.023 | |
| amine metabolic process | GO:0009308 | 45 | 0.023 | |
| response to acid chemical | GO:0001101 | 111 | 0.023 | |
| regulation of protein localization | GO:0032880 | 231 | 0.023 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.023 | |
| lateral ventricle development | GO:0021670 | 11 | 0.023 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.023 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.023 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.023 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.023 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.022 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.022 | Human |
| protein localization to nucleus | GO:0034504 | 121 | 0.022 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.022 | |
| adaptive immune response | GO:0002250 | 155 | 0.022 | |
| epithelial cell development | GO:0002064 | 159 | 0.022 | |
| dendrite development | GO:0016358 | 115 | 0.022 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.022 | |
| memory | GO:0007613 | 58 | 0.022 | |
| transdifferentiation | GO:0060290 | 1 | 0.022 | |
| angiogenesis | GO:0001525 | 201 | 0.022 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.022 | |
| endodermal cell fate commitment | GO:0001711 | 12 | 0.022 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.022 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.021 | |
| formation of organ boundary | GO:0010160 | 1 | 0.021 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.021 | |
| olfactory learning | GO:0008355 | 2 | 0.021 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.021 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.021 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.021 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.021 | |
| snrna processing | GO:0016180 | 1 | 0.021 | |
| mesenchyme development | GO:0060485 | 152 | 0.021 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.021 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.021 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.021 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.021 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.020 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.020 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.020 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.020 | |
| t cell proliferation | GO:0042098 | 120 | 0.020 | |
| interferon gamma production | GO:0032609 | 67 | 0.020 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.020 | |
| regulation of odontogenesis | GO:0042481 | 18 | 0.020 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.020 | |
| protein monoubiquitination | GO:0006513 | 11 | 0.020 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.020 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.020 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.020 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.020 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.019 | |
| response to alcohol | GO:0097305 | 48 | 0.019 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.019 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.019 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.019 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.019 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.019 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.019 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.019 | |
| response to steroid hormone | GO:0048545 | 56 | 0.019 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.019 | |
| endocytosis | GO:0006897 | 168 | 0.019 | |
| membrane organization | GO:0061024 | 245 | 0.018 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.018 | |
| ossification | GO:0001503 | 216 | 0.018 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.018 | |
| multicellular organism growth | GO:0035264 | 161 | 0.018 | |
| stem cell maintenance | GO:0019827 | 130 | 0.018 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.018 | |
| cognition | GO:0050890 | 149 | 0.018 | |
| sensory organ boundary specification | GO:0008052 | 1 | 0.018 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.018 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.018 | |
| maintenance of location | GO:0051235 | 89 | 0.018 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.017 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.017 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.017 | Human |
| bone mineralization | GO:0030282 | 54 | 0.017 | |
| snrna 3 end processing | GO:0034472 | 1 | 0.017 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.017 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.017 | |
| spermatid development | GO:0007286 | 108 | 0.017 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.017 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.017 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.017 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.017 | |
| glucose homeostasis | GO:0042593 | 128 | 0.017 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.017 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.017 | |
| response to sterol | GO:0036314 | 4 | 0.017 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.017 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.016 | Human |
| regulation of transferase activity | GO:0051338 | 263 | 0.016 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.016 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.016 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.016 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.016 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.016 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.016 | |
| neuron migration | GO:0001764 | 122 | 0.016 | |
| response to light stimulus | GO:0009416 | 135 | 0.016 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.016 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.016 | |
| wound healing | GO:0042060 | 157 | 0.016 | |
| positive regulation of t cell proliferation | GO:0042102 | 52 | 0.016 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.016 | |
| positive regulation of retinoic acid receptor signaling pathway | GO:0048386 | 3 | 0.016 | |
| negative regulation of gene silencing | GO:0060969 | 2 | 0.016 | |
| protein localization to organelle | GO:0033365 | 185 | 0.016 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.016 | |
| response to growth factor | GO:0070848 | 198 | 0.015 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.015 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.015 | |
| forebrain development | GO:0030900 | 302 | 0.015 | |
| pallium development | GO:0021543 | 120 | 0.015 | |
| nuclear import | GO:0051170 | 95 | 0.015 | |
| gastrulation | GO:0007369 | 116 | 0.015 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.015 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.015 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.015 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.015 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| compound eye development | GO:0048749 | 1 | 0.015 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.015 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.015 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.015 | |
| action potential | GO:0001508 | 78 | 0.015 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.015 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.015 | |
| protein import | GO:0017038 | 101 | 0.015 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.015 | |
| spliceosomal complex disassembly | GO:0000390 | 1 | 0.015 | |
| midbrain hindbrain boundary development | GO:0030917 | 9 | 0.014 | |
| genitalia development | GO:0048806 | 37 | 0.014 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.014 | |
| regulation of protein transport | GO:0051223 | 163 | 0.014 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.014 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.014 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.014 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.014 | |
| cellular response to retinoic acid | GO:0071300 | 25 | 0.014 | |
| regulation of defense response | GO:0031347 | 233 | 0.014 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.014 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.014 | |
| epidermis development | GO:0008544 | 187 | 0.014 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.014 | |
| dna recombination | GO:0006310 | 92 | 0.014 | |
| male meiosis i | GO:0007141 | 16 | 0.014 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.014 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.014 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.014 | |
| negative regulation of circadian rhythm | GO:0042754 | 8 | 0.014 | |
| embryonic placenta development | GO:0001892 | 98 | 0.014 | |
| mitotic spindle checkpoint | GO:0071174 | 9 | 0.013 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.013 | |
| microtubule based process | GO:0007017 | 236 | 0.013 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.013 | |
| bone development | GO:0060348 | 120 | 0.013 | |
| respiratory tube development | GO:0030323 | 167 | 0.013 | |
| positive regulation of immature t cell proliferation in thymus | GO:0033092 | 3 | 0.013 | |
| maintenance of apical basal cell polarity | GO:0035090 | 3 | 0.013 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.013 | |
| microtubule cytoskeleton organization involved in mitosis | GO:1902850 | 4 | 0.013 | |
| protein processing | GO:0016485 | 163 | 0.013 | |
| response to retinoic acid | GO:0032526 | 56 | 0.013 | |
| immunoglobulin production | GO:0002377 | 73 | 0.013 | |
| regulation of dna recombination | GO:0000018 | 34 | 0.013 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.013 | |
| atp metabolic process | GO:0046034 | 75 | 0.013 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.013 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.013 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.013 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.013 | |
| cartilage development | GO:0051216 | 140 | 0.013 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.013 | |
| regulation of tooth mineralization | GO:0070170 | 2 | 0.012 | |
| chromatin remodeling | GO:0006338 | 32 | 0.012 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.012 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.012 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.012 | |
| negative regulation of dna recombination | GO:0045910 | 13 | 0.012 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.012 | |
| signal transduction downstream of smoothened | GO:0007227 | 4 | 0.012 | |
| spinal cord development | GO:0021510 | 81 | 0.012 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.012 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.012 | |
